What You Should Know:
- Appalachian Regional Healthcare (ARH), based in Lexington, Ky., will use Biofourmis’ virtual care and AI-based predictive analytics technology to support a new Rural Home Hospital program delivering acute hospital-level care inside patients’ homes--including a clinical trial studying this care model in rural areas.
- ARH joins Blessing Health System—which is also using Biofourmis’ solution—as one of only two U.S. participants
Read More
Kidney Disease
DaVita to Invest $15M in Biopharma Company Rockwell Medical
What You Should Know:
- Rockwell Medical, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management expands its partnership with kidney care leader DaVita Inc. Rockwell Medical has been working to revise certain terms of its supply contracts with customers in an effort to stabilize its concentrates business.
- The amended supply agreement is designed to enable Rockwell Medical's concentrates business the potential to operate
Read More
Powered by Biofourmis, Blessing Health System Partners Launches Home Hospital Services
What You Should Know:
- Blessing Health System, an integrated rural health system selects Biofourmis, a virtual care and digital therapeutics provider to launch its own home hospital services.
- As part of the selection, Biofourmis is supporting the health system with its turnkey, end-to-end, home hospital solution for participation in the Rural Home Hospital project.
Delivering Acute-Level Hospital Care Inside Patients’ Homes
This new program allows caregivers to
Read More
Researchers Develop AI Method for Personalized Diabetes Treatment
What You Should Know:
- Hitachi, U of U Health, and Regenstrief researchers partnered to develop and test a new AI method to improve personalized care for diabetes patients needing complex drug treatment.
- The new AI method can now be used to help determine an optimal drug regimen for a specific patient.
Hitachi, University of Utah Health, and Regenstrief Institute today announced the development of an artificial intelligence (AI) method to improve care for patients with type 2
Read More
Fresenius Health Partners, InterWell Health, and Cricket Health Announce $2.4B Merger
What You Should Know:
- Cricket Health is announcing today that it will merge with Fresenius Health Partners (the value-based care arm of Fresenius), and InterWell Health, to form the nation’s premier, value-based kidney care provider with a totally new model of addressing kidney disease. The new company will operate under the InterWell Health brand and is valued at $2.4B.
- Together, Fresenius Health Partners, InterWell Health, and Cricket Health will drive innovation and industry
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Patient Data & Decentralized Web: The Key To A Healthier Future?
Interoperable data and IT systems in healthcare has long been an enigma - many have tried to tackle the challenge, but until now very little has changed. A truly interconnected network that brings together the infinite number of siloed systems used in healthcare services around the world, and even within the same county, has remained elusive. And so too has patient access to their own data. Considered by some as two distinct problems, however in reality the answer to both is the same: web 3.0
Read More
NANI Makes Equity Investment in Strive Health for Risk Payment
What You Should Know:
- Strive Health, the national leader in value-based kidney care, and Nephrology Associates of Northern Illinois and Northern Indiana (NANI), the nation’s largest independent nephrology group, today announced a strategic partnership to jointly pursue and manage global risk payment models.
- This partnership will benefit people with chronic kidney disease (CKD) and end stage kidney disease (ESKD) through a “whole patient” approach that enhances lives and communities
Read More
Dosis Expands Dosing Platform to Personalize Anemia Management
What You Should Know:
- Dosis, the AI-powered precision dosing platform on a mission to transform healthcare, has announced the release of its Strategic Iron Advisor (SIA) tool, the first precision dosing tool on the market for intravenous iron.
- SIA is a sub-module that works with Dosis’s existing anemia tool, Strategic Anemia Advisor (SAA), to personalize anemia management. SAA is widely used nationwide to personalize Erythropoiesis Stimulating Agents (ESA) dosing, and the SIA
Read More
Sentara Healthcare Taps Sensyne to Deploy Clinical Algorithms for CKD & CHF
What You Should Know:
- Sentara Healthcare, a health system in NC and VA, just partnered with Sensyne Health to drive clinical research with ethical AI.
- As part of a collaboration agreement, Sentara also becomes the first of several U.S. health systems that will partner with Sensyne to implement new clinical algorithms to support patients with CKD and CHF. The agreement will enable the ethical application of clinical AI research by Sensyne through analyzing Sentara’s patient dataset to
Read More
